Artiva Biotherapeutics, Inc. (ARTV) vs C4 Therapeutics, Inc. (CCCC)
A side-by-side comparison of Artiva Biotherapeutics, Inc. and C4 Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARTV
Artiva Biotherapeutics, Inc.
$7.13HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CCCC
C4 Therapeutics, Inc.
$2.99HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ARTV vs CCCC
growth of $100 · dividends reinvested · last 2yARTV -40.6% (-22.9%/yr)CCCC -52.2% (-30.8%/yr)ARTV compounded faster over this window
ARTV CCCC
ARTV vs CCCC: by the numbers
- •ARTV is the larger company ($349M vs $331M market cap).
- •Both run net losses; ARTV's is the smaller (0.00% vs -289.44% net margin).
Metrics side by side
Valuation
| Metric | ARTV | CCCC |
|---|---|---|
| P/S ratio | N/A | 9.44 |
| P/B ratio | 1.00 | 1.34 |
Profitability
| Metric | ARTV | CCCC |
|---|---|---|
| Gross margin | 0.00% | 77.81% |
| Operating margin | 0.00% | -290.68% |
| Net margin | 0.00% | -289.44% |
| ROE | -26.14% | -41.02% |
| ROIC | -27.16% | -35.92% |
Growth (annualized)
| Metric | ARTV | CCCC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 0.65% |
| Total return CAGR (5Y) | N/A | -41.77% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.